Internal Medicine · Lynn, MA
NPI
1851494892
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
269 Union St
Lynn, MA, 01901
Phone (781) 581-3900
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.7M
1,627 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Hanna Haptu prescribed most often to Medicare patients was Tivicay (Dolutegravir Sodium), with 117 prescriptions and refills. In total Hanna Haptu wrote 1,627 Medicare prescriptions that cost $1.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Tivicay Dolutegravir Sodium | 117 | 137 | 15 | $301K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 108 | 145 | 16 | $559K |
| Atorvastatin Calcium Generic | 81 | 137 | 14 | $758 |
| Rosuvastatin Calcium Generic | 74 | 161 | 19 | $1,030 |
| Pifeltro Doravirine | 69 | 82 | Under 11 | $138K |
| Metoprolol Succinate Generic | 64 | 140 | 14 | $829 |
| Isoniazid Generic | 58 | 60 | 14 | $848 |
| Descovy Emtricitabine/Tenofov Alafenam | 56 | 62 | Under 11 | $139K |
| Vemlidy Tenofovir Alafenamide | 53 | 53 | Under 11 | $79K |
| Lisinopril Generic | 43 | 106 | 12 | $319 |
| Gabapentin Generic | 41 | 45 | Under 11 | $571 |
| Amlodipine Besylate Generic | 38 | 68 | Under 11 | $307 |
| Omeprazole Generic | 37 | 75 | Under 11 | $428 |
| Spironolactone Generic | 29 | 52 | Under 11 | $235 |
| Metformin Hcl Generic | 26 | 46 | Under 11 | $217 |
Brand drugs: 615 claims; generic drugs: 988 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Hanna Haptu were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.